$2.97
-0.0100-0.34%
At Close: -
$2.95
-0.02-0.67%
After Hours: 4:54 PM EDT
15 minutes delayed
BioCardia
BCDANASDAQ
BioCardia (NASDAQ:BCDA) Stock, Analyst Ratings, Price Targets, Predictions
BioCardia Inc has a consensus price target of $2, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on May 29, 2024, November 14, 2023, and October 11, 2023. With an average price target of $4 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 35.59% upside for BioCardia Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Dawson James
1calculated from analyst ratings
Analyst Ratings for BioCardia
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/29/2024 | Buy Now | 35.59% | HC Wainwright & Co. | Joseph Pantginis | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2023 | Buy Now | 35.59% | HC Wainwright & Co. | Joseph Pantginis | → $60 | Reiterates | Buy → Buy | Get Alert |
| 10/11/2023 | Buy Now | 35.59% | HC Wainwright & Co. | Joseph Pantginis | → $60 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | Buy Now | 35.59% | HC Wainwright & Co. | Joseph Pantginis | $135 → $60 | Maintains | Buy | Get Alert |
| 08/10/2023 | Buy Now | 205.08% | HC Wainwright & Co. | Joseph Pantginis | → $135 | Reiterates | Buy → Buy | Get Alert |
| 07/24/2023 | Buy Now | 205.08% | HC Wainwright & Co. | Joseph Pantginis | $135 → $135 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2023 | Buy Now | 205.08% | HC Wainwright & Co. | Joseph Pantginis | → $135 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | Buy Now | 205.08% | HC Wainwright & Co. | Joseph Pantginis | → $135 | Reiterates | Buy → Buy | Get Alert |
| 03/30/2023 | Buy Now | 205.08% | HC Wainwright & Co. | Joseph Pantginis | → $135 | Reiterates | → Buy | Get Alert |
| 11/11/2022 | Buy Now | — | Dawson James | Jason Kolbert | — | Downgrade | Buy → Neutral | Get Alert |
| 12/20/2021 | Buy Now | 205.08% | HC Wainwright & Co. | Joseph Pantginis | → $135 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for BioCardia (BCDA) stock?
The latest price target for BioCardia (NASDAQ:BCDA) was reported by HC Wainwright & Co. on May 29, 2024. The analyst firm set a price target for $4.00 expecting BCDA to rise to within 12 months (a possible 35.59% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for BioCardia (BCDA)?
The latest analyst rating for BioCardia (NASDAQ:BCDA) was provided by HC Wainwright & Co., and BioCardia reiterated their buy rating.
When was the last upgrade for BioCardia (BCDA)?
There is no last upgrade for BioCardia
When was the last downgrade for BioCardia (BCDA)?
The last downgrade for BioCardia Inc happened on November 11, 2022 when Dawson James changed their price target from N/A to N/A for BioCardia Inc.
When is the next analyst rating going to be posted or updated for BioCardia (BCDA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioCardia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioCardia was filed on May 29, 2024 so you should expect the next rating to be made available sometime around May 29, 2025.
Is the Analyst Rating BioCardia (BCDA) correct?
While ratings are subjective and will change, the latest BioCardia (BCDA) rating was a reiterated with a price target of $4.00 to $4.00. The current price BioCardia (BCDA) is trading at is $2.95, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.